Sonalis Consumer Products Ltd.
Sonalis Cons Product
₹ 0.00
0.00 (0.00)%
NSE
BSE
FMCG
Small-cap - With a market cap of ₹25.64 Cr.
| EX-Date | Purpose |
|---|---|
| 21 08 2023 | Audited Results |
| 09 11 2023 | Half Yearly Results |
| 11 01 2024 | Audited Results |
| 27 03 2024 | Preferential Issue of shares & Increase in Authorised Capital Inter alia, to approve the Raising of Funds and Reconstitution of Board of Directors or any other Items with the permission of Chariman. |
| 19 04 2024 | Preferential Issue of shares & With Reference to the Outcome of Board Meeting that the Board has decided to issue 2,30,00,000 Equity Shares in form of Preferential Allotment or Private Placement or Qualified Institutional Placement for which the Board Decided to conduct the Board meeting on 19th April, 2024 in which the Allotment of Equity Shares Method will be decided further and declaration of Name of Allotees. |
| 21 10 2024 | Right Issue of Equity Shares |
| 26 10 2024 | Rights Issue(Cancelled) (Cancelled) |
| 26 10 2024 | Rights Issue |
| 31 10 2024 | Half Yearly Results Inter alia, to consider and approve the following businesses: - 1. To consider and approve the Unaudited Standalone Financial Results along with Limited Review Report by Auditor thereon of the Company for the Half Year ended September 30, 2024. 2. Appointment of Mr. Devendrabhai Keshavbhai Virdiya as an Additional Non-Executive Director. 3. Any other business(s) with permission of Chair, if any. |
| 18 11 2024 | Inter alia, to consider and approve:- 1. To consider, discuss and decide various matters in connection with the Rights Issue such as Rights Issue size, Right Issue Price and Rights Entitlement Ratio. 2. Appointment of Ms. Sweta Agrawal as a Company Secretary and Compliance Officer of the Company. 3. Any other business(s) with permission of Chair, if any. |
| 24 03 2025 | Inter alia, to consider and approve: 1. Total number of Equity Shares and Rights Issue size, Rights Issue Price, Record Date, Rights Issue Period, Rights entitlement ratio, other terms of the Rights Issue (including renunciation and fractional and zero entitlements): 2. To take a note for In-principal approval received from the Bombay Stock Exchange Limited. 3. Any other business(s) with permission of Chair, if any. |
| 29 04 2025 | Audited Results & Half Yearly Results |
| 05 05 2025 | Half Yearly Results (Revised) & Audited Results |
| 02 09 2025 | A.G.M. |
| 18 10 2025 | Inter alia, to consider and approve:- 1. To consider a proposal for raising of funds by way of issuance of share warrant through Private Placement/Preferential Issue to Promoters and Promoter Group of the Company. 2. Any other business, if any with permission of chairman. |
| 11 11 2025 | 1. To consider and approve the Standalone Unaudited Financial Results along with Limited Review Report thereon for the Half Year ended on September 30, 2025. 2. Acceptance of Resignation of Mr. Devendrakumar Keshavlal Viradiya, Director of the Company. 3. Any other business, if any with permission of chairman. We request you to kindly take the above on your record. Thanking you & Half Yearly Results |
